ETRACS CMCI Total Return ETN Series B
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
A fund that holds many companies, so profit, growth, price and debt are not measured for it as for one company.
AI analysis
An AI analyst reads ETRACS CMCI Total Return ETN Series B's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Profitability
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about ETRACS CMCI Total Return ETN Series B
Is ETRACS CMCI Total Return ETN Series B a good stock to buy?
A fund that holds many companies, so profit, growth, price and debt are not measured for it as for one company. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the ETRACS CMCI Total Return ETN Series B AI analysis
What does ETRACS CMCI Total Return ETN Series B do?
The ETN Series B is senior unsecured debt securities issued by UBS. The index is designed to be a diversified benchmark for commodities as an asset class. It is in Asset Management.
How has ETRACS CMCI Total Return ETN Series B stock done over the past year?
Up 30.8% over the past twelve months, to $35.88. It traded between $26.61 and $40.09 and is 10.5% below its high.
Prices: daily closes to Nov 10, 2026. Fundamentals: company reports via invest-like data.